Approvals/TGA/Hospira Anzatax (Paclitaxel) Injection Concentrate 100 mg/16.7 mL Vial

Approved

STANDARD

Hospira Anzatax (Paclitaxel) Injection Concentrate 100 mg/16.7 mL Vial

Hospira Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: df66726a8ea47171
Product Name: Hospira Anzatax (Paclitaxel) Injection Concentrate 100 mg/16.7 mL Vial
Artg Id: 333063
Artg Name: Hospira Anzatax (Paclitaxel) Injection Concentrate 100 mg/16.7 mL Vial
Sponsor: Hospira Australia Pty Ltd
Company Detail Path: /organization/hospira-australia-pty-ltd
Artg Date: 2020-04-01
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: LIE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

df66726a8ea47171

Type

Standard